Improved bioavailability of levodopa using floatable spray-coated microcapsules for the management of Parkinson’s disease
Oral administration of levodopa (LD) is the gold standard in managing Parkinson’s disease (PD). Although LD is the most effective drug in treating PD, chronic administration of LD induces levodopa-induced dyskinesia. A continuous and sustained provision of LD to the brain could, therefore, reduce pe...
Saved in:
Main Authors: | Baek, Jong-Suep, Tee, Jie Kai, Pang, Yi Yun, Tan, Ern Yu, Lim, Kah Leong, Ho, Han Kiat, Loo, Joachim Say Chye |
---|---|
Other Authors: | School of Materials Science & Engineering |
Format: | Article |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/92269 http://hdl.handle.net/10220/49468 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson’s Disease
by: Baek J.-S., et al.
Published: (2018) -
Levodopa-induced oromandibular dystonia in progressive supranuclear palsy
by: Tan E.K., et al.
Published: (2018) -
The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in Singapore
by: Wu, J, et al.
Published: (2024) -
Influence of Levodopa therapy on static balance in Parkinson’s disease
by: Sirinthip Kamolsawat, et al.
Published: (2018) -
Multi-drug-loaded Microcapsules with Controlled Release for Management of Parkinson's Disease
by: Baek, Jong-Suep, et al.
Published: (2016)